Announcements Trials
Browse Landscape

Phase

Phase 2 79Phase 3 18Phase 2/3 7Phase 1/2 7Phase NA 6Phase 4 5Phase 1 4

Status

Unknown 9Completed 9Recruiting 5Not yet recruiting 5Terminated 3Active not recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 2Breast 2NET 1Endocrine 1

Conditions

Small Cell Lung Carcinoma 2Triple Negative Breast Neoplasms 1Neuroendocrine Tumors 1Breast Neoplasms 1

Interventions

anlotinib 5Cisplatin 5Carboplatin 5Immune Checkpoint Inhibitors 4tislelizumab 3sintilimab 3lenvatinib 3Oxaliplatin 3Fluorouracil 3Capecitabine 3Bevacizumab 3venetoclax 2Rosuvastatin Calcium 2Prednisone 2Megestrol Acetate 2Leucovorin 2Gemcitabine 2Drug Therapy 2Dexmedetomidine 2Dexamethasone 2Aspirin 2zanubrutinib 1xiaojin wan 1trastuzumab deruxtecan 1trametinib 1toripalimab 1tocilizumab 1testosterone 17 beta-cypionate 1tenofovir alafenamide 1telitacicept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Not yet recruiting × Carboplatin × Clear all
NCT07093931 2025-07-30

Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer

Shandong Cancer Hospital and Institute

Phase 4 Not yet recruiting
468 enrolled
Breast

Breast Neoplasms

NCT06951841 2025-04-30

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

China Medical University, China

Phase 4 Not yet recruiting
31 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT06931145 2025-04-23

Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer

Peking Union Medical College Hospital

Phase 4 Not yet recruiting
50 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT06485739 2024-07-03

Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma

First Affiliated Hospital Xi'an Jiaotong University

Phase 4 Not yet recruiting
20 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT05843292 2023-06-06

NeoSTEP

Shanghai Jiao Tong University School of Medicine

Phase 4 Not yet recruiting
48 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡